Product Information
BREYNA 160-4.5 MCG INHALER is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $22.7870 per GM under NDC 00378750332. Its NADAC has been published 149 times since Oct 18, 2023.
FDA first approved this application on Mar 15, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
160; 4.5 ug/1; ug/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378750332
Classification
Generic
Dosage Form
AEROSOL, METERED
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
BUDESONIDE; FORMOTEROL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA211699FDA Approved
3/15/2022
TE Code
AB
On Market Since
7/31/2023
Pharmacological Classes
Price Statistics
The NADAC for BREYNA 160-4.5 MCG INHALER has been published 149 times since Oct 18, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.7870 per GM |
|---|---|
| All-time high | $23.9755 (Jan 10, 2024) |
| All-time low | $16.9210 (May 22, 2024) |
| 52-week high | $23.5829 |
| 52-week low | $22.7583 |
| Median price | $23.1209 |
| Average price | $22.7506 |
| Largest weekly change | +35.0% (Jun 19, 2024) |
| Weeks tracked | 149 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Budesonide and Formoterol Fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BREYNA 160-4.5 MCG INHALER?
The current National Average Drug Acquisition Cost (NADAC) for BREYNA 160-4.5 MCG INHALER, manufactured by Mylan Pharmaceuticals Inc., is $22.7870 per GM (NDC 00378750332), effective Aug 19, 2026.
How has the price of BREYNA 160-4.5 MCG INHALER changed over time?
Over the history we have for it, the NADAC for BREYNA 160-4.5 MCG INHALER has held within roughly two percent of its current level. It has been tracked across 149 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for BREYNA 160-4.5 MCG INHALER?
Since Oct 18, 2023, the NADAC for BREYNA 160-4.5 MCG INHALER has ranged from a low of $16.9210 (May 22, 2024) to a high of $23.9755 (Jan 10, 2024), with a median of $23.1209 per GM.
Are there cheaper alternatives to BREYNA 160-4.5 MCG INHALER?
No other NADAC-published product currently shares the active ingredient and strength of BREYNA 160-4.5 MCG INHALER in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BREYNA 160-4.5 MCG INHALER?
BREYNA 160-4.5 MCG INHALER (NDC 00378750332) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.